Ischemia–reperfusion and chronic injuries associated with small-for-size liver transplantation (SFSLT) impair the regeneration of liver graft and induce liver fibrosis. Mesenchymal stem cells (MSCs) can prevent the development of liver fibrosis, and hepatocyte growth factor (HGF) can also attenuate liver cirrhosis. Our previous studies have demonstrated that higher occurrence of liver fibrosis existed in rats post-SFSLT, and that implantation of HGF/MSCs, the human HGF (hHGF)-expressing MSCs, can improve liver regeneration, reduce mortality of rats, as well as have the potent antifibrotic effect in this SFSLT model. In the present study, we implanted HGF/MSCs into liver grafts via the portal vein and investigated their role in antifibrosis effect, using a 30% SFSLT rat model. Fibrosis indexes, including laminin (LN), hyaluronic acid (HA) levels in serum and hydroxyproline (Hyp) content in the liver grafts, the expression of transforming growth factor-β1 (TGF-β1), rat HGF (rHGF), α-smooth muscle actin (α-SMA) in hepatic stellate cells (HSCs), alanine aminotransferase (ALT), total bilirubin (BIL), and albumin (ALB) levels in serum, in rats in different treatment groups were assessed at different time points. We found that HGF/MSCs significantly inhibited the formation of liver fibrosis in rats undergoing SFSLT, while MSCs and HGF had synergistic effects in the process. The antifibrosis effect of HGF/MSCs may have contributed in modulating the activation and apoptosis of HSCs, elevating the rHGF expression level, and decreasing the TGF-β1 secretion of activated HSCs. These studies suggest that HGF/MSCs may be a novel therapeutic option for the treatment of liver fibrosis after SFSLT.
Get full access to this article
View all access options for this article.
References
1.
KiuchiT, KasaharaM, UryuharaK, InomataY, UemotoS, AsonumaK, EgawaH, FujitaS, HayashiM, TanakaK. 1999. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation, 67:321–327.
2.
Ben-HaimM, EmreS, FishbeinTM, SheinerPA, BodianCA, Kim-SchlugerL, SchwartzME, MillerCM. 2001. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl, 7:948–953.
3.
GuoL, HagaS, EnosawaS, NaruseK, HariharaY, SugawaraY, IraniK, MakuuchiM, OzakiM. 2004. Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model. Am J Transplant, 4:879–887.
YaoA, LiX, PuL, ZhongJ, LiuX, YuY, ZhangF, KongL, SunB, WangX. 2007. Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation. Transpl Immunol, 18:37–43.
6.
ManK, FanST, LoCM, LiuCL, FungPC, LiangTB, LeeTK, TsuiSH, NgIO, ZhangZW, WongJ. 2003. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg, 237:256–264.
7.
ManK, LoCM, NgIO, WongYC, QinLF, FanST, WongJ. 2001. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg, 136:280–285.
8.
LiangTB, ManK, Kin-Wah LeeT, Hong-Teng TsuiS, LoCM, XuX, ZhengSS, FanST, WongJ. 2003. Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation, 75:673–678.
Abdel AzizMT, AttaHM, MahfouzS, FouadHH, Roshdy HH AhmedNK, RashedLA, SabryD, HassounaAA, HasanNM. 2007. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem, 40:893–899.
12.
SakaidaI, TeraiS, YamamotoN, AoyamaK, IshikawaT, NishinaH, OkitaK. 2004. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology, 40:1304–1311.
13.
TögelF, CohenA, ZhangP, YangY, HuZ, WestenfelderC. 2009. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev, 18:475–485.
14.
LeeK, MajumdarMK, BuyanerD, HendricksJK, PittengerMF, MoscaJD. 2001. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther, 3:857–866.
KamadaN, CameRY. 1983. A surgical experience with five hundred thirty liver transplants in the rat. Surgery, 93,1 Pt 1:64–69.
17.
LiJ, DahmenU, DirschO, ShenK, GuY, BroelschCE. 2002. Modified sleeve anastomosis for reconstruction of the hepatic artery in rat liver transplantation. Microsurgery, 22:62–68.
18.
NakamuraT, SakataR, UenoT, SataM, UenoH. 2000. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology, 32:247–255.
19.
WangJ, TaharaK, HakamataY, MutohH, MurakamiT, TakahashiM, KusamaM, KobayashiE. 2002. Auxiliary partial liver grafting in rats: effect of host hepatectomy on graft regeneration, and review of literature on surgical technique. Microsurgery, 22:371–377.
20.
ZhongZ, SchwabeRF, KaiY, HeL, YangL, BunzendahlH, BrennerDA, LemastersJJ. 2006. Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation, 82:241–250.
ScheenstraR, PeetersPM, VerkadeHJ, GouwAS. 2009. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology, 49:880–886.
24.
SongH, KwonK, LimS, KangSM, KoYG, XuZ, ChungJH, KimBS, LeeH, JoungB, ParkS, ChoiD, JangY, ChungNS, YooKJ, HwangKC. 2005. Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells, 19:402–407.
25.
NeussS, BecherE, WöltjeM, TietzeL, Jahnen-DechentW. 2004. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells, 22:405–414.
26.
LiuKX, KatoY, NarukawaM, KimDC, HananoM, HiguchiO, NakamuraT, SugiyamaY. 1992. Importance of the liver in plasma clearance of hepatocyte growth factors in rats. Am J Physiol, 263,5 Pt 1:G642–G649.
27.
LiuML, MarsWM, ZarnegarR, MichalopoulosGK. 1994. Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am J Pathol, 144:129–140.
28.
BorderWA, NobleNA. 1997. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int, 51:1388–1396.
29.
BöttingerEP, BitzerM. 2002. TGF-beta signaling in renal disease. J Am Soc Nephrol, 13:2600–2610.
30.
SchnaperHW, HayashidaT, HubchakSC, PonceletAC. 2003. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol, 284:F243–F252.
31.
CowinAJ, KallincosN, HatzirodosN, RobertsonJG, PickeringKJ, CouperJ, BelfordDA. 2001. Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats. Cell Tissue Res, 306:239–250.
32.
DaiC, YangJ, LiuY. 2002. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol, 13:411–422.
33.
HayashiS, MorishitaR, HigakiJ, AokiM, MoriguchiA, KidaI, YoshikiS, MatsumotoK, NakamuraT, KanedaY, OgiharaT. 1996. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun, 220:539–545.
34.
MatsumotoK, NakamuraT. 2001. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int, 59:2023–2038.
35.
LiuY. 2002. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens, 11:23–30.
36.
MatsumotoK, TajimaH, OkazakiH, NakamuraT. 1992. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem, 267:24917–24920.
MizunoS, MatsumotoK, NakamuraT. 2001. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int, 59:1304–1314.
39.
ZhaoDC, LeiJX, ChenR, YuWH, ZhangXM, LiSN, XiangP. 2005. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol, 11:3431–3440.
40.
van PollD, ParekkadanB, ChoCH, BerthiaumeF, NahmiasY, TillesAW, YarmushML. 2008. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology, 47:1634–1643.
41.
KallisYN, AlisonMR, ForbesSJ. 2007. Bone marrow stem cells and liver disease. Gut, 56:716–724.
SonBR, Marquez-CurtisLA, KuciaM, WysoczynskiM, TurnerAR, RatajczakJ, RatajczakMZ, Janowska-WieczorekA. 2006. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells, 24:1254–1264.
44.
OyagiS, HiroseM, KojimaM, OkuyamaM, KawaseM, NakamuraT, OhgushiH, YagiK. 2006. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol, 44:742–748.
45.
ParekkadanB, van PollD, MegeedZ, KobayashiN, TillesAW, BerthiaumeF, YarmushML. 2007. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun, 363:247–252.
46.
K innairdT, StabileE, BurnettMS, ShouM, LeeCW, BarrS, FuchsS, EpsteinSE. 2004. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109:1543–1549.
47.
SilvaGV, LitovskyS, AssadJA, SousaAL, MartinBJ, VelaD, CoulterSC, LinJ, OberJ, VaughnWK, BrancoRV, OliveiraEM, HeR, GengYJ, WillersonJT, PerinEC. 2005. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111:150–156.
48.
WangX, GeS, McNamaraG, HaoQL, CrooksGM, NoltaJA. 2003. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood, 101:4201–4208.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
